Healthcare >> CEO Interviews >> June 18, 2001
MICHAEL A. MARTINO is President, Chief Executive Officer and a Director
of Sonus Pharmaceuticals Inc. Mr. Martino joined Sonus in September 1998
as President, Chief Operating Officer and a Director and was appointed
Chief Executive Officer in July 1999. From 1983 to 1998, he held
numerous positions of increasing responsibility in strategic planning,
business development, marketing and sales, and general management with
Mallinckrodt, Inc., a global healthcare products company, including
serving as Vice President and General Manager of the Nuclear Division.
Mr. Martino received a BA in Business from Roanoke College and an MBA
from Virginia Tech. He sits on the Presidents Advisory Board of Roanoke
College and is a member of the Board of Trustees of Cascadia Community
College. In addition, Mr. Martino is a past Chairman of the Board of the
Washington Biotechnology and Biomedical Association (WBBA). Profile
Sonus Pharmaceuticals?
Mr. Martino: Sonus was founded in 1991 and went public in 1995. The
founding strategy of the company
